Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. - Wikidata - awgldk - TriplyDB

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

http://www.wikidata.org/entity/Q36586072

about

Research recommendations for selected IARC-classified agents Endocrine disrupters as obesogens Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males Di-(2-Ethylhexyl)-Phthalate (DEHP) Causes Impaired Adipocyte Function and Alters Serum Metabolites Environmental immune disruptors, inflammation and cancer risk Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death Mechanistic considerations for human relevance of cancer hazard of di(2-ethylhexyl) phthalate Human health effects of tetrachloroethylene: key findings and scientific issues The effects of di(2-ethylhexyl)phthalate on rat liver in relation to selenium status Prenatal exposure to di-(2-ethylhexyl) phthalate (DEHP) affects reproductive outcomes in female mice Maternal exposure to di-2-ethylhexylphthalate and adverse delivery outcomes: A systematic review.Nuclear receptors and endocrine disruptors in fetal and neonatal testes: a gapped landscape.Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms Urinary phthalates are associated with higher blood pressure in childhood.A longitudinal study of urinary phthalate excretion in 58 full-term and 67 preterm infants from birth through 14 months Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006.Effect of a Large Dose of Di (2-ethylhexyl) phthalate (DEHP) on Hepatic Peroxisome in Cynomolgus Monkeys (Macaca Fascicularis).Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.Urinary phthalates and increased insulin resistance in adolescents.Food Emulsifier Glycerin Monostearate Increases Internal Exposure Levels of Six Priority Controlled Phthalate Esters and Exacerbates Their Male Reproductive Toxicities in Rats.Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.Regulation of mRNA Translation Is a Novel Mechanism for Phthalate Toxicity Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice.PPARalpha- and DEHP-Induced Cancers Mechanisms of peroxisome proliferator-induced DNA hypomethylation in rat liver Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2.A systematic approach for identifying and presenting mechanistic evidence in human health assessments.Interference of pollutants with PPARs: endocrine disruption meets metabolism.Urinary Phthalate Metabolites and Biomarkers of Oxidative Stress in a Mexican-American Cohort: Variability in Early and Late Pregnancy.

P2860

Q23912511-26326DBC-A100-42FA-A338-4A1CF19DF1C0 Q24647272-4CB9DB36-1451-4A60-A467-783659488207 Q24672743-C8C21660-922C-49BE-A086-2EC9A8066775 Q27342141-009BD9B9-45D9-4EA3-9DC5-5C63BE2B7D1C Q28080870-5F311A7B-8DB0-43C1-851B-2F40FEB4B6C7 Q28080874-8464A7A6-9901-432F-80A4-FD8D1F3467E7 Q28256111-7503A52B-7457-4F3D-98C3-3D06AAB1896E Q28383923-124129E8-D85C-43E7-9AFE-AE0CE439071C Q28395705-95F08326-3313-48FF-BDC1-6A24B96CB95D Q28395788-C3ABF72B-ED35-4AE4-ACE6-4DFC38444A77 Q30249008-D667EE21-056B-4956-B608-A984AC5D02F1 Q30388742-4188C6A4-80D1-4711-B234-7BF6577A6434 Q30495487-F69C2701-9124-4287-B40D-A36452D25F54 Q33569334-07B59FD7-0C3A-42FD-8397-F627EF4C1E05 Q33702683-58A681D6-A5D4-44AD-B6AA-003C779E0CF1 Q33820132-25FE1EBB-6318-46DD-AAA7-59802EE7C2DB Q34131545-43B6020A-6B67-4208-A106-217EE994C4F5 Q34189111-E10BBA77-355E-47EF-B721-C0D73F5D5527 Q34477550-F9E12A72-9600-413D-B413-9955CB0E5C9F Q34623928-DA00BBB1-095D-416B-BC17-9E8E6CDD4760 Q35022586-EB34C290-7E91-4654-8822-6D5C715E00F1 Q35033943-176051E1-90A7-4484-8322-9E9556FCE579 Q35603991-CD7DECCF-3326-4650-9C31-C790E426242A Q35653376-32249F08-A4C1-47FF-84CB-8DF39F040CF4 Q35675055-D7E98F2D-8AB4-440D-B592-4F4B879FA0DF Q35691236-D0D5FA48-F3AE-48AA-8333-6E8C45A82228 Q35926509-1D616D41-0BC5-46B4-8C9F-507DB7943CD2 Q36117116-1AC7ADB9-12E0-4BC9-9C1C-06D0A04D0374 Q36202782-9B646713-4E51-4A91-B05D-31BBDC8CB794 Q36228108-FCB01635-FE76-4623-8150-EF35E5FED19E Q36298157-42878D12-16C6-4B84-BF27-437536D37988 Q36325488-FE14FD4A-D650-47B4-9F0E-8836C9DD4EEC Q36397694-C4ECC6F9-8AFD-4BE0-925A-5350FE9F3514 Q36857053-1F401147-C398-4C47-BC79-D15FAEDA4D20 Q36946714-1E3FAED1-0BE6-4570-A1C2-41B8D4368379 Q37125240-F53375AA-78F1-4D6A-8D0E-FF2D8C5954A8 Q37168382-A9319845-AB48-4B0D-9462-966C0882F5BD Q37281574-5BCC70CC-969B-4864-8E20-A9C03B84BC7C Q37349822-F5EBE13C-B7E4-45CA-B7F9-7ABCCE63F20F Q37518424-9E289EC0-68BC-4E34-9C9C-646AD85577C7

P2860

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

http://www.wikidata.org/entity/Q36586072

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@ast

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@en

type

label

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@ast

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@en

prefLabel

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@ast

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

@en

P1433

Q36586072-DA33EB87-5363-442C-AB4A-69FBCD12802E

P1476

Q36586072-C8D9019A-A7DE-48FB-84D1-CE36599291CC

P2093

Q36586072-01E79166-BA34-4966-BD6F-FA9DCC2CF6F5

Q36586072-30FEA96A-679A-4621-A7E2-C1D2F50359ED

P2860

Q36586072-01180510-1D0C-4E72-BADF-ACD479E18818

Q36586072-038F8732-0FAF-4F0C-A0D7-330C74DA82E5

Q36586072-06BD7E60-12AE-49CA-B2CC-13F4869FCCB4

Q36586072-07DD5FC5-1D0F-4ACA-8CC4-C8513D1DEC34

Q36586072-0BAFD3DD-AB95-4775-9D62-4A1409D2AB22

Q36586072-11041DB5-91C9-43F8-8743-92ADE6084AA9

Q36586072-1433B6DC-7730-4FD6-9CA5-3F17D0DCC687

Q36586072-14C0EC6F-DF81-4259-BF4A-952C21B18ED9

Q36586072-163E63A7-EC2C-44E9-9FE2-D4B9F5187F25

Q36586072-1752DCE1-F076-4895-9545-E186E3F9D0AF

P304

Q36586072-9B2CD8B5-51A1-4A73-8DFE-1686C4EAD141

P31

Q36586072-7FA4DDA6-7CF1-4DD4-B100-97EC663A91CC

P356

Q36586072-554EF478-893F-4CF3-857F-AB865B392E12

P407

Q36586072-80332FE0-67FB-4276-BBED-0457E6CB1A62

P433

Q36586072-C8A6E56F-4681-4042-A0E0-63AF0B00A144

P478

Q36586072-65D10C8E-3695-426F-9700-849A88B02E4A

P50

Q36586072-539AC34A-480B-416E-8510-DE401B8C1E7C

P577

Q36586072-2E0D1FDE-9C99-4CBF-8BB7-7FB0D6560AC8

P5875

Q36586072-8CAD11C2-15DD-4444-83A6-85A20508BE09

P698

Q36586072-1D39EB44-BA8A-4B5D-9AC1-84E4B8BA7C45

P932

Q36586072-0C9ACBAF-5DCC-4B1F-95F9-47CE51036818

P356

10408440600779065

P1433

Critical Reviews in Toxicology

P1476

Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver

@en

P2093

Ivan Rusyn

http://www.w3.org/2001/XMLSchema#string

Michael L Cunningham

http://www.w3.org/2001/XMLSchema#string

P2860

Role of kupffer cells in peroxisome proliferator-induced hepatocyte proliferation

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

Levels of seven urinary phthalate metabolites in a human reference population

Activation of PPARalpha and PPARgamma by environmental phthalate monoesters

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

P304

459-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10408440600779065

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6836191

http://www.w3.org/2001/XMLSchema#string

P698

16954067

http://www.w3.org/2001/XMLSchema#string

P932

2614359

http://www.w3.org/2001/XMLSchema#string